NCT04540874View on ClinicalTrials.gov

A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

November 12, 2020

Study Completion Date

November 12, 2020

Conditions
Healthy
Interventions
DRUG

BI 894416

BI 894416

DRUG

Placebo

Placebo

Trial Locations (1)

162-0053

Clinical Research Hospital Tokyo, Tokyo, Shinjuku-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY